2020 American Transplant Congress » Poster Session B: Kidney Deceased Donor Allocation

3:30pm-4:00pm

Enhancing Kidney Allograft Decision Making: An Organ Offer Simulation Study

J. Mansy¹, J. Case¹, D. Stewart², H. McGehee², K. Lindblad², R. Schaffer¹, J. Fisher¹, J. Rice¹, S. Kurian¹, C. Marsh¹

3:30pm-4:00pm

Geographic Variation in Listing for Kidney Transplantation: A State-Level Assessment of Access among Patients with End-Stage Renal Disease in the United States

M. N. Mustian, H. Qu, D. Anderson, P. A. MacLennan, R. D. Reed, C. Kale, B. Orandi, B. A. Shelton, V. Kumar, M. Hanaway, J. E. Locke

3:30pm-4:00pm

Higher State-Level Demand for Renal Transplantation is Associated with Lower Deceased Donor Kidney Transplantation Rate

A. C. Kale, H. Qu, P. MacLennan, R. Reed, D. Anderson, M. N. Mustian, B. Orandi, B. Shelton, V. Kumar, M. J. Hanaway, J. E. Locke

3:30pm-4:00pm

How Advantaged are Kidney-Pancreas Candidates for Deceased-Donor Kidney Transplants, and is This Appropriate?

A. Massie, M. Nguyen, R. Wesson, M. Henderson, N. Desai, D. Segev

3:30pm-4:00pm

Increased Graft Survival Following Implementation of the Kidney Allocation Score

M. L. Samoylova¹, B. I. Shaw¹, W. Irish², S. J. Kesseli¹, A. Connor¹, A. S. Barbas¹, L. McElroy¹, K. V. Ravindra¹

3:30pm-4:00pm

KDPI-Based Kidney Discard Risk Assessment

S. Mehrotra¹, M. Barah², K. Bui³

3:30pm-4:00pm

Machine Learning to Predict Deceased Donor Kidney Biopsy Results

C. Martinez, A. Placona

3:30pm-4:00pm

One Organ Procurement Organization Coordinates 43% of All Uncontrolled Donation after Circulatory Determination of Death Donors Recovered in the United States Over 24 Years

R. D. Hasz, S. M. West, H. M. Nathan

3:30pm-4:00pm

One Year of the OPTN’s SLK Allocation Policy

A. Wilk¹, R. Formica², A. Wiseman³, R. Hirose⁴, D. Mulligan², D. Stewart¹

3:30pm-4:00pm

The Eplet-Mismatch Landscape in Kidney Patients and Deceased Donors in British Columbia

J. Tran¹, O. Gunther², J. Lan¹, M. Kadatz¹, R. Sapir-Pichhadze³, P. A. Keown¹

3:30pm-4:00pm

The New UK National Kidney Allocation Scheme with Maximized ‘D4/R4’ Kidney Transplants: Appropriate Donor to Recipient Matching or System Overstretch?

R. Pearson, E. Murray, P. Thompson, P. Mark, M. Clancy, J. Asher

3:30pm-4:00pm

When CPRA Zero is Not the Hero: Does KAS Disadvantage Unsensitized Relisted Patients?

M. Casey, Z. Su, M. Mohamed Ahmed, D. Taber, E. Weeda, T. Morinelli, P. Mauldin, K. Soliman, M. A. Posadas-Salas, V. Rao, D. DuBay